AGÕæÈ˹ٷ½

STOCK TITAN

[8-K] GENPACT LIMITED Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Credo Technology Group (CRDO) â€� Form 4 insider transaction: Chi Fung Cheng, the company’s Chief Technology Officer and director, disclosed the sale of 55,000 ordinary shares on 01-Aug-2025 under a Rule 10b5-1 trading plan adopted 06-Sep-2024.

  • Seven separate trades were executed at weighted-average prices ranging $103.64â€�$109.55 per share.
  • Approximate gross proceeds: about US$5.9 million (derived from share/price data disclosed).
  • Post-sale, Cheng (via the Cheng Huang Family Trust) still beneficially owns 7,108,961 ordinary shares, indicating the disposition represents â‰�0.8 % of his indirect holdings.

No derivative transactions were reported. The filing appears routine and does not indicate any change in corporate strategy or fundamentals.

Credo Technology Group (CRDO) � Transazione interna Form 4: Chi Fung Cheng, Chief Technology Officer e direttore della società, ha comunicato la vendita di 55.000 azioni ordinarie il 01-ago-2025 nell’ambito di un piano di trading Rule 10b5-1 adottato il 06-set-2024.

  • Sono state eseguite sette operazioni separate a prezzi medi ponderati compresi tra $103,64 e $109,55 per azione.
  • Proventi lordi approssimativi: circa 5,9 milioni di dollari USA (calcolati dai dati di prezzo/azioni comunicati).
  • Dopo la vendita, Cheng (tramite il Cheng Huang Family Trust) detiene ancora beneficiariamente 7.108.961 azioni ordinarie, il che indica che la cessione rappresenta circa il 0,8% delle sue partecipazioni indirette.

Non sono state riportate transazioni su strumenti derivati. La comunicazione sembra di routine e non indica alcun cambiamento nella strategia aziendale o nei fondamentali.

Credo Technology Group (CRDO) � Transacción interna Formulario 4: Chi Fung Cheng, Director de Tecnología y director de la empresa, reveló la venta de 55,000 acciones ordinarias el 01-ago-2025 bajo un plan de negociación Rule 10b5-1 adoptado el 06-sep-2024.

  • Se realizaron siete operaciones separadas a precios promedio ponderados entre $103.64 y $109.55 por acción.
  • Ingresos brutos aproximados: alrededor de 5.9 millones de dólares estadounidenses (derivado de los datos de acciones/precio divulgados).
  • Tras la venta, Cheng (a través del Cheng Huang Family Trust) aún posee beneficiariamente 7,108,961 acciones ordinarias, lo que indica que la disposición representa aproximadamente el 0.8 % de sus participaciones indirectas.

No se reportaron transacciones con derivados. La presentación parece rutinaria y no indica ningún cambio en la estrategia corporativa o en los fundamentos.

Credo Technology Group (CRDO) â€� Form 4 ë‚´ë¶€ìž� 거래: 회사ì� 최고기술책임ìž�(CTO) ê²� ì´ì‚¬ì� Chi Fung Chengê°€ 2025ë…� 8ì›� 1ì¼ì— 2024ë…� 9ì›� 6ì� 채íƒë� Rule 10b5-1 거래 계íšì—� ë”°ë¼ 55,000ì£� 보통ì£� 매ë„ë¥� 공시했습니다.

  • 7ê±´ì˜ ê°œë³„ 거래가 주당 $103.64~$109.55ì� 가중í‰ê·� 가격으ë¡� ì²´ê²°ë˜ì—ˆìŠµë‹ˆë‹�.
  • 대략ì ì� ì´� 수ìµ: 공개ë� 주ì‹/ê°€ê²� ë°ì´í„°ë¥¼ 기반으로 ì•� 590ë§� 달러입니ë‹�.
  • ë§¤ë„ í›� Chengì€(Cheng Huang Family Trustë¥� 통해) 여전íž� 7,108,961ì£� 보통ì£�ë¥� 실질 소유하고 있으ë©�, ì´ëŠ” 매ë„ê°€ ê·¸ì˜ ê°„ì ‘ 보유 ì§€ë¶„ì˜ ì•� 0.8%ì—� í•´ë‹¹í•¨ì„ ë‚˜íƒ€ëƒ…ë‹ˆë‹�.

파ìƒìƒí’ˆ 거래ëŠ� ë³´ê³ ë˜ì§€ 않았습니ë‹�. ì´ë²ˆ ì œì¶œì€ ì¼ìƒì ì¸ 것으ë¡� ë³´ì´ë©� 회사 ì „ëžµì´ë‚˜ 기본 사항ì—� 변화가 있ìŒì� 나타내지 않습니다.

Credo Technology Group (CRDO) � Transaction d’initié Formulaire 4 : Chi Fung Cheng, directeur technique et administrateur de la société, a déclaré la vente de 55 000 actions ordinaires le 01 août 2025 dans le cadre d’un plan de négociation Rule 10b5-1 adopté le 06 septembre 2024.

  • Sept transactions distinctes ont été exécutées à des prix moyens pondérés allant de 103,64 $ à 109,55 $ par action.
  • Produit brut approximatif : environ 5,9 millions de dollars américains (calculé à partir des données de prix/actions divulguées).
  • Après la vente, Cheng (via le Cheng Huang Family Trust) détient toujours bénéficiairement 7 108 961 actions ordinaires, ce qui indique que la cession représente environ 0,8 % de ses participations indirectes.

Aucune transaction sur produits dérivés n’a été signalée. Le dépôt semble routinier et n’indique aucun changement dans la stratégie d’entreprise ou les fondamentaux.

Credo Technology Group (CRDO) � Insider-Transaktion Form 4: Chi Fung Cheng, Chief Technology Officer und Direktor des Unternehmens, meldete den Verkauf von 55.000 Stammaktien am 01. August 2025 im Rahmen eines am 06. September 2024 eingeführten Rule 10b5-1 Handelsplans.

  • Sieben separate Transaktionen wurden zu gewichteten Durchschnittspreisen zwischen pro Aktie ausgeführt.
  • Ungefähre Bruttoerlöse: ca. 5,9 Millionen US-Dollar (basierend auf den offengelegten Aktien-/Preisdaten).
  • Nach dem Verkauf hält Cheng (über den Cheng Huang Family Trust) weiterhin wirtschaftlich 7.108.961 Stammaktien, was darauf hinweist, dass die Veräußerung etwa 0,8 % seiner indirekten Beteiligungen ausmacht.

Es wurden keine Derivatgeschäfte gemeldet. Die Meldung erscheint routinemäßig und deutet nicht auf eine Änderung der Unternehmensstrategie oder der Fundamentaldaten hin.

Positive
  • Sale executed under a disclosed Rule 10b5-1 plan, signalling pre-arranged, non-opportunistic intent.
  • Insider retains a substantial 7.1 million-share position, implying continued alignment with shareholders.
Negative
  • 55,000 shares sold for roughly US$5.9 million could be perceived as profit-taking.
  • All reported transactions were sales; no offsetting purchases to indicate increasing insider conviction.

Insights

TL;DR: Routine 55 k-share 10b5-1 sale; negligible vs. 7.1 m stake, limited market signal.

The CTO’s 55,000-share sale (~US$5.9 m) is <1 % of his indirect ownership and was executed under a pre-established 10b5-1 plan, reducing concerns about opportunistic selling. While insider sales can pressure sentiment, the small percentage and continued large holding (7.1 m shares) suggest confidence remains. Impact on valuation or fundamentals is minimal; I view the disclosure as neutral for investors.

Credo Technology Group (CRDO) � Transazione interna Form 4: Chi Fung Cheng, Chief Technology Officer e direttore della società, ha comunicato la vendita di 55.000 azioni ordinarie il 01-ago-2025 nell’ambito di un piano di trading Rule 10b5-1 adottato il 06-set-2024.

  • Sono state eseguite sette operazioni separate a prezzi medi ponderati compresi tra $103,64 e $109,55 per azione.
  • Proventi lordi approssimativi: circa 5,9 milioni di dollari USA (calcolati dai dati di prezzo/azioni comunicati).
  • Dopo la vendita, Cheng (tramite il Cheng Huang Family Trust) detiene ancora beneficiariamente 7.108.961 azioni ordinarie, il che indica che la cessione rappresenta circa il 0,8% delle sue partecipazioni indirette.

Non sono state riportate transazioni su strumenti derivati. La comunicazione sembra di routine e non indica alcun cambiamento nella strategia aziendale o nei fondamentali.

Credo Technology Group (CRDO) � Transacción interna Formulario 4: Chi Fung Cheng, Director de Tecnología y director de la empresa, reveló la venta de 55,000 acciones ordinarias el 01-ago-2025 bajo un plan de negociación Rule 10b5-1 adoptado el 06-sep-2024.

  • Se realizaron siete operaciones separadas a precios promedio ponderados entre $103.64 y $109.55 por acción.
  • Ingresos brutos aproximados: alrededor de 5.9 millones de dólares estadounidenses (derivado de los datos de acciones/precio divulgados).
  • Tras la venta, Cheng (a través del Cheng Huang Family Trust) aún posee beneficiariamente 7,108,961 acciones ordinarias, lo que indica que la disposición representa aproximadamente el 0.8 % de sus participaciones indirectas.

No se reportaron transacciones con derivados. La presentación parece rutinaria y no indica ningún cambio en la estrategia corporativa o en los fundamentos.

Credo Technology Group (CRDO) â€� Form 4 ë‚´ë¶€ìž� 거래: 회사ì� 최고기술책임ìž�(CTO) ê²� ì´ì‚¬ì� Chi Fung Chengê°€ 2025ë…� 8ì›� 1ì¼ì— 2024ë…� 9ì›� 6ì� 채íƒë� Rule 10b5-1 거래 계íšì—� ë”°ë¼ 55,000ì£� 보통ì£� 매ë„ë¥� 공시했습니다.

  • 7ê±´ì˜ ê°œë³„ 거래가 주당 $103.64~$109.55ì� 가중í‰ê·� 가격으ë¡� ì²´ê²°ë˜ì—ˆìŠµë‹ˆë‹�.
  • 대략ì ì� ì´� 수ìµ: 공개ë� 주ì‹/ê°€ê²� ë°ì´í„°ë¥¼ 기반으로 ì•� 590ë§� 달러입니ë‹�.
  • ë§¤ë„ í›� Chengì€(Cheng Huang Family Trustë¥� 통해) 여전íž� 7,108,961ì£� 보통ì£�ë¥� 실질 소유하고 있으ë©�, ì´ëŠ” 매ë„ê°€ ê·¸ì˜ ê°„ì ‘ 보유 ì§€ë¶„ì˜ ì•� 0.8%ì—� í•´ë‹¹í•¨ì„ ë‚˜íƒ€ëƒ…ë‹ˆë‹�.

파ìƒìƒí’ˆ 거래ëŠ� ë³´ê³ ë˜ì§€ 않았습니ë‹�. ì´ë²ˆ ì œì¶œì€ ì¼ìƒì ì¸ 것으ë¡� ë³´ì´ë©� 회사 ì „ëžµì´ë‚˜ 기본 사항ì—� 변화가 있ìŒì� 나타내지 않습니다.

Credo Technology Group (CRDO) � Transaction d’initié Formulaire 4 : Chi Fung Cheng, directeur technique et administrateur de la société, a déclaré la vente de 55 000 actions ordinaires le 01 août 2025 dans le cadre d’un plan de négociation Rule 10b5-1 adopté le 06 septembre 2024.

  • Sept transactions distinctes ont été exécutées à des prix moyens pondérés allant de 103,64 $ à 109,55 $ par action.
  • Produit brut approximatif : environ 5,9 millions de dollars américains (calculé à partir des données de prix/actions divulguées).
  • Après la vente, Cheng (via le Cheng Huang Family Trust) détient toujours bénéficiairement 7 108 961 actions ordinaires, ce qui indique que la cession représente environ 0,8 % de ses participations indirectes.

Aucune transaction sur produits dérivés n’a été signalée. Le dépôt semble routinier et n’indique aucun changement dans la stratégie d’entreprise ou les fondamentaux.

Credo Technology Group (CRDO) � Insider-Transaktion Form 4: Chi Fung Cheng, Chief Technology Officer und Direktor des Unternehmens, meldete den Verkauf von 55.000 Stammaktien am 01. August 2025 im Rahmen eines am 06. September 2024 eingeführten Rule 10b5-1 Handelsplans.

  • Sieben separate Transaktionen wurden zu gewichteten Durchschnittspreisen zwischen pro Aktie ausgeführt.
  • Ungefähre Bruttoerlöse: ca. 5,9 Millionen US-Dollar (basierend auf den offengelegten Aktien-/Preisdaten).
  • Nach dem Verkauf hält Cheng (über den Cheng Huang Family Trust) weiterhin wirtschaftlich 7.108.961 Stammaktien, was darauf hinweist, dass die Veräußerung etwa 0,8 % seiner indirekten Beteiligungen ausmacht.

Es wurden keine Derivatgeschäfte gemeldet. Die Meldung erscheint routinemäßig und deutet nicht auf eine Änderung der Unternehmensstrategie oder der Fundamentaldaten hin.

0001398659FALSE00013986592025-07-312025-07-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 31, 2025
GENPACT LIMITED
(Exact name of registrant as specified in its charter)
Bermuda     001-3362698-0533350
(State or other jurisdiction
of incorporation)
   (Commission
     File Number)
(I.R.S. Employer
Identification No.)
Canon's Court, 22 Victoria Street
Hamilton HM 12, Bermuda
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (441298-3300
Not Applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each classTrading SymbolName of each exchange on which registered
Common shares, par value $0.01 per shareGNew York Stock Exchange
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On July 31, 2025, Genpact Limited, a Bermuda company (the “Company”), announced that its Board of Directors (the “Board”) has appointed Thimaya Subaiya to the Board, effective as of July 31, 2025.

Mr. Subaiya, age 47, currently serves as the Executive Vice President of Operations at Cisco Systems, Inc., overseeing all Operational functions, Security and Trust, supply chain and IT. Prior to this role, he was Cisco's Chief Transformation Officer, focusing on accelerating the company's shift to a software and as-a-service company, and Chief Customer Experience Officer, driving innovation in the Cisco Success Portfolio and accelerating customer adoption, partner engagement and overall growth for Cisco's Services. Prior to joining Cisco in 2018, Mr. Subaiya was at Salesforce and Oracle. Mr. Subaiya holds an MBA from the ENPC School of International Management.

In accordance with the Company’s current compensation program for non-employee directors, Mr. Subaiya will receive an annual base cash retainer of $70,000 and an annual grant of restricted share units with a value of $210,000 based on the closing share price of a Company common share on the grant date. For 2025, Mr. Subaiya will receive a pro-rated cash retainer of approximately $29,000 and a pro-rated annual grant of restricted share units with a value of $87,500 based on the closing share price of a Company common share on the grant date. Mr. Subaiya has also entered into the Company’s standard form of indemnification agreement for directors of the Company.



Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  GENPACT LIMITED
     
Date: August 5, 2025 By: /s/ Heather D. White
  Name: Heather D. White
  Title: Senior Vice President, Chief Legal Officer and Secretary

FAQ

How many Credo (CRDO) shares did the CTO sell?

The filing shows 55,000 ordinary shares were sold on 01-Aug-2025.

At what prices were the CRDO shares sold?

Weighted-average sale prices ranged from $103.64 to $109.55 per share across seven trades.

Was the sale pre-planned?

Yes. The sales were executed under a Rule 10b5-1 trading plan adopted on 06-Sep-2024.

How many CRDO shares does the insider still own?

Post-transaction, the Cheng Huang Family Trust holds 7,108,961 ordinary shares.

Does this insider sale materially affect Credo’s outlook?

The sale represents �0.8 % of the insider’s stake and is considered routine, with no stated impact on company operations or guidance.
Genpact Limited

NYSE:G

G Rankings

G Latest News

G Latest SEC Filings

G Stock Data

7.41B
160.56M
0.91%
103.71%
3.97%
Information Technology Services
Services-management Consulting Services
Bermuda
HAMILTON